Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,058 | 95 | 98.7% |
| Education | $27.38 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $508.33 | 17 | $0 (2023) |
| Novo Nordisk Inc | $423.45 | 22 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $310.51 | 9 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $152.90 | 9 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $140.56 | 16 | $0 (2018) |
| SANOFI-AVENTIS U.S. LLC | $122.06 | 7 | $0 (2018) |
| Amgen Inc. | $100.95 | 4 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $100.70 | 1 | $0 (2017) |
| Sunovion Pharmaceuticals Inc. | $93.11 | 3 | $0 (2017) |
| Lilly USA, LLC | $44.34 | 3 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $129.87 | 2 | GlaxoSmithKline, LLC. ($129.87) |
| 2021 | $130.81 | 2 | GlaxoSmithKline, LLC. ($130.81) |
| 2019 | $124.12 | 2 | GlaxoSmithKline, LLC. ($98.71) |
| 2018 | $509.73 | 38 | Merck Sharp & Dohme Corporation ($129.50) |
| 2017 | $1,191 | 54 | Novo Nordisk Inc ($404.01) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 02/15/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $4.87 | General |
| Category: RESPIRATORY | ||||||
| 12/07/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $98.71 | General |
| Category: RESPIRATORY | ||||||
| 03/26/2019 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $25.41 | General |
| Category: Neuroscience | ||||||
| 11/29/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: DIABETES | ||||||
| 11/15/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $11.39 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/08/2018 | MannKind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $11.96 | General |
| Category: DIABETES MEDICINE | ||||||
| 11/08/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $5.09 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/25/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA, STEGLATRO | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/18/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $8.63 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/11/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $5.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/04/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Neuroscience | ||||||
| 10/04/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $8.93 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/20/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $9.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/19/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/13/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: DIABETES | ||||||
| 09/13/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), BELSOMRA | Food and Beverage | In-kind items and services | $5.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/30/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $20.68 | General |
| Category: DIABETES | ||||||
| 08/30/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/16/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/16/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/09/2018 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, JANUMET XR | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/02/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 989 | 1,300 | $307,548 | $94,403 |
| 2022 | 16 | 1,032 | 1,393 | $306,086 | $101,517 |
| 2021 | 13 | 966 | 1,436 | $292,730 | $103,566 |
| 2020 | 17 | 841 | 1,173 | $250,658 | $78,875 |
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 182 | 182 | $58,968 | $24,925 | 42.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 176 | 281 | $83,738 | $24,625 | 29.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 224 | 359 | $72,518 | $19,144 | 26.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 42 | 42 | $20,034 | $7,316 | 36.5% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 72 | 102 | $20,604 | $4,265 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $17,784 | $3,552 | 20.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $7,392 | $2,793 | 37.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 32 | 37 | $5,513 | $1,650 | 29.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,881 | $1,365 | 72.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $4,784 | $1,231 | 25.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 83 | 116 | $4,176 | $1,042 | 24.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 14 | $4,172 | $766.97 | 18.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 27 | $3,294 | $724.68 | 22.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $1,008 | $684.18 | 67.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 29 | $1,682 | $319.54 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 234 | 368 | $103,112 | $30,776 | 29.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 151 | 151 | $46,688 | $20,254 | 43.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 192 | 342 | $65,164 | $19,657 | 30.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 65 | 65 | $29,333 | $11,337 | 38.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 73 | 90 | $17,188 | $5,036 | 29.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $5,710 | $2,266 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $8,257 | $2,171 | 26.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $9,590 | $2,146 | 22.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 29 | 29 | $2,863 | $2,033 | 71.0% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 16 | 19 | $5,326 | $1,838 | 34.5% |
About Dr. Lymar Bik, M.D
Dr. Lymar Bik, M.D is a Internal Medicine healthcare provider based in Atascadero, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1164530622.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lymar Bik, M.D has received a total of $2,086 in payments from pharmaceutical and medical device companies, with $129.87 received in 2023. These payments were reported across 98 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,058).
As a Medicare-enrolled provider, Bik has provided services to 3,828 Medicare beneficiaries, totaling 5,302 services with total Medicare billing of $378,361. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Atascadero, CA
- Active Since 08/26/2006
- Last Updated 04/20/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1164530622
Products in Payments
- Tresiba (Drug) $288.56
- ANORO (Drug) $234.37
- TRELEGY ELLIPTA (Drug) $135.68
- Victoza (Drug) $134.89
- JANUVIA (Drug) $129.50
- AREXVY (Drug) $125.00
- SYMBICORT (Drug) $114.99
- BEVESPI AEROSPHERE (Drug) $106.08
- XIFAXAN (Drug) $100.70
- UTIBRON (Drug) $93.11
- FARXIGA (Drug) $89.44
- STIOLTO (Drug) $84.98
- Aimovig (Biological) $83.09
- TOUJEO (Drug) $64.27
- SOLIQUA (Drug) $57.79
- JARDIANCE (Drug) $54.49
- ENTRESTO (Drug) $25.78
- Repatha (Biological) $17.86
- FLUZONE HIGH-DOSE (Drug) $15.69
- STIOLTO RESPIMAT (Drug) $13.43
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Atascadero
Ben Cooke, Md, MD
Internal Medicine — Payments: $6,318
Dr. Jason Green, M.d, M.D
Internal Medicine — Payments: $3,391
Robin Alleyne, Md, MD
Internal Medicine — Payments: $394.29
Madeleine Hernandez, Md, MD
Internal Medicine — Payments: $392.71
Ms. Emily Luk, M.d, M.D
Internal Medicine — Payments: $124.56
Hossein Akhavan, M.d, M.D
Internal Medicine — Payments: $117.40